Chest computed tomography outcomes in a randomized clinical trial in cystic fibrosis: Lessons learned from the first ataluren phase 3 study

por Tiddens, Harm A. W. M., Andrinopoulou, Eleni-Rosalina, McIntosh, Joe, Elborn, J. Stuart, Kerem, Eitan, Bouma, Nynke, Bosch, Jochem, Kemner-van de Corput, Mariette
Publicado 2020

The effect of CFTR modulators on structural lung disease in cystic fibrosis

por Mok, L. Clara, Garcia-Uceda, Antonio, Cooper, Matthew N., Kemner-Van De Corput, Mariette, De Bruijne, Marleen, Feyaerts, Nathalie, Rosenow, Tim, De Boeck, Kris, Stick, Stephen, Tiddens, Harm A. W. M.
Publicado 2023

The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6–11 with cystic fibrosis in a real-world setting

por McNally, Paul, Linnane, Barry, Williamson, Michael, Elnazir, Basil, Short, Christopher, Saunders, Clare, Kirwan, Laura, David, Rea, Kemner-Van de Corput, Mariette P. C., Tiddens, Harm A.W.M., Davies, Jane C, Cox, Des W
Publicado 2023